Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Devresse

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Transplantation|July 9, 2021
Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant RecipientsHélène Georgery, Arnaud Devresse, Jean-Cyr Yombi, et al.
Transplantation|October 29, 2021
Monoclonal Antibody Therapy for SARS-CoV-2 Infection in Kidney Transplant Recipients: A Case Series From BelgiumGuillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2018
No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experienceArnaud Devresse, Claire Tinel, Agathe Vermorel, et al.
Transplantation|September 14, 2021
Delayed Humoral Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Kidney Transplant CohortHélène Georgery, Arnaud Devresse, Imane Saad Albichr, et al.
Current Opinion in Oncology|January 30, 2019
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?Pauline De Bruyn, Dirk Van Gestel, Piet Ost, et al.
Kidney Medicine|June 29, 2022
In Reply to 'Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations'Guillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Kidney Medicine|May 2, 2022
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case SeriesGuillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Kidney Medicine|August 11, 2020
COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From BelgiumArnaud Devresse, Leila Belkhir, Bernard Vo, et al.
Translational Gastroenterology and Hepatology|November 11, 2025
Chronic hepatitis E and hepatitis E seroprevalence in immunosuppressed patients: a prospective studyMarie Philippart, Michael Peeters, Sophie Lamoral, et al.
Transplantation Proceedings|March 8, 2020
Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals EraArnaud Devresse, Bénédicte Delire, Jeffrey V Lazarus, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Transplantation|July 9, 2021
Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant RecipientsHélène Georgery, Arnaud Devresse, Jean-Cyr Yombi, et al.
Transplantation|October 29, 2021
Monoclonal Antibody Therapy for SARS-CoV-2 Infection in Kidney Transplant Recipients: A Case Series From BelgiumGuillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2018
No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experienceArnaud Devresse, Claire Tinel, Agathe Vermorel, et al.
Transplantation|September 14, 2021
Delayed Humoral Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Kidney Transplant CohortHélène Georgery, Arnaud Devresse, Imane Saad Albichr, et al.
Current Opinion in Oncology|January 30, 2019
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?Pauline De Bruyn, Dirk Van Gestel, Piet Ost, et al.
Kidney Medicine|June 29, 2022
In Reply to 'Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations'Guillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Kidney Medicine|May 2, 2022
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case SeriesGuillaume Fernandes, Arnaud Devresse, Anais Scohy, et al.
Kidney Medicine|August 11, 2020
COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From BelgiumArnaud Devresse, Leila Belkhir, Bernard Vo, et al.
Translational Gastroenterology and Hepatology|November 11, 2025
Chronic hepatitis E and hepatitis E seroprevalence in immunosuppressed patients: a prospective studyMarie Philippart, Michael Peeters, Sophie Lamoral, et al.
Transplantation Proceedings|March 8, 2020
Eliminating Hepatitis C Virus From a Prevalent Kidney Transplant Recipient Population: A Single-Center Study in Belgium in the Direct-Acting Antivirals EraArnaud Devresse, Bénédicte Delire, Jeffrey V Lazarus, et al.
Pageof 9